ImmunoGen, Inc.
IMGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $275 | $479 | $294 | $176 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $18 | $14 | $22 | $27 |
| Inventory | -$29 | -$21 | -$30 | -$33 |
| Other Curr. Assets | $11 | $7 | $8 | $5 |
| Total Curr. Assets | $275 | $479 | $294 | $176 |
| Property Plant & Equip (Net) | $15 | $17 | $20 | $23 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $59 | $30 | $41 | $37 |
| Total NC Assets | $74 | $47 | $61 | $59 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $349 | $526 | $355 | $236 |
| Liabilities | – | – | – | – |
| Payables | $45 | $18 | $10 | $10 |
| Short-Term Debt | $4 | $4 | $5 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $14 | $44 | $29 | $0 |
| Other Curr. Liab. | $59 | $35 | $78 | $64 |
| Total Curr. Liab. | $122 | $101 | $122 | $77 |
| LT Debt | $11 | $15 | $19 | $24 |
| Deferred Rev, NC | $36 | $48 | $81 | $127 |
| Deferred Tax Liab, NC | -$11 | -$15 | -$19 | -$24 |
| Other NC Liab. | $35 | $52 | $62 | $107 |
| Total NC Liab. | $71 | $99 | $143 | $234 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $193 | $200 | $266 | $312 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | -$1,694 | -$1,471 | -$1,332 | -$1,287 |
| AOCI | $1,850 | $0 | $1,421 | $1,211 |
| Other Equity | -$2 | $1,795 | -$2 | -$2 |
| Total Equity | $156 | $326 | $90 | -$76 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $349 | $526 | $355 | $236 |
| Net Debt | -$260 | -$460 | -$270 | -$149 |